Halozyme Therapeutics | Umsatzkosten



Cost Of Sales Veränderung Datum
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amarin USD 26.02M 1.3M 2024-09
Amgen USD 3.11B 198M 2024-12
Baxter International USD 1.74B 73M 2024-12
Cytokinetics 463K 79.14M 2024-09
Eli Lilly USD 2.4B 233M 2024-12
Halozyme Therapeutics USD 42.06M 7.37M 2024-12
Indivior 59M 7M 2024-09
Intra Cellular Therapies USD 20.4M 5.1M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
MannKind USD 17.6M 119K 2024-12
Pfizer USD 5.65B 781M 2024-12
United Therapeutics USD 75.9M 7.2M 2024-12



Halozyme Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.